(Q34225314)

31 July 2017

1 reference

title

Tryptophan metabolites and brain disorders (English)

1 reference

31 July 2017

Trevor W Stone

1

0 references

author name string

Gillian M Mackay

2

1 reference

31 July 2017

Caroline M Forrest

3

1 reference

31 July 2017

Catherine J Clark

4

1 reference

31 July 2017

L Gail Darlington

5

1 reference

31 July 2017

publication date

1 July 2003

1 reference

Clinical Chemistry and Laboratory Medicine

31 July 2017

published in

1 reference

31 July 2017

volume

41

1 reference

31 July 2017

issue

7

1 reference

31 July 2017

page(s)

852-859

1 reference

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Quinolinate neurotoxicity in cortical cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Kynurenines in the CNS: from endogenous obscurity to therapeutic importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Neurotoxic effect induced by quinolinic acid in dissociated cell culture of mouse hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Quinolinate and kainate neurotoxicity in neostriatal cultures is potentiated by co-culturing with neocortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Quinolinic acid is a potent lipid peroxidant in rat brain homogenates

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Free radical scavenger OPC-14117 attenuates quinolinic acid-induced NF-kappaB activation and apoptosis in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Quinolinic acid and lymphocyte subsets in the intrathecal compartment as biomarkers of SIV infection and simian AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Metal-mediated oxidative damage to cellular and isolated DNA by certain tryptophan metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Kynurenic acid is decreased in cerebrospinal fluid of patients with infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Glucose metabolism and hemoglobin reactivity in human red blood cells exposed to the tryptophan metabolites 3-hydroxyanthranilate, quinolinate and picolinate

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Increased brain 3-hydroxykynurenine in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze task

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Increase in kynurenic acid in Huntington's disease motor cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Temporal and spatial changes of quinolinic acid immunoreactivity in the gerbil hippocampus following transient cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Quinolinic acid is increased in CSF and associated with mortality after traumatic brain injury in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Quinolinic acid in the cerebrospinal fluid of children after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

Elevation of the neurotoxin quinolinic acid occurs following spinal cord trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.129

21 January 2018

Identifiers

DOI

10.1515/CCLM.2003.129

1 reference

31 July 2017

1 reference